Requisite Capital Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-45,000
Closed -$708K 58
2022
Q3
$708K Hold
45,000
0.24% 19
2022
Q2
$628K Buy
+45,000
New +$628K 0.21% 25
2022
Q1
Hold
0
75
2021
Q4
Hold
0
75